BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 2609991)

  • 1. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
    Antalóczy Z; Kekes E
    Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
    Floris B; Paoletti G; Pelizza L; Bertulla A; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):139-43. PubMed ID: 1906434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
    Bowles MJ; Smith L; Glover DR
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():85-90. PubMed ID: 2196372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF; Pouleur H; Cocco G; Wolff AA
    Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-ischaemic and anti-anginal activity of atenolol, nifedipine and their combination in stable, chronic effort angina.
    Lai C; Onnis E; Pirisi R; Orani E; Delogu G; Cherchi A
    Drugs Exp Clin Res; 1988; 14(11):699-705. PubMed ID: 3073077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-anginal effect of Tenormin (atenolol).
    Antalóczy Z; Kékes E
    Ther Hung; 1992; 40(2):58-63. PubMed ID: 1462277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.
    Quyyumi AA; Wright C; Mockus L; Fox KM
    Br Med J (Clin Res Ed); 1984 Oct; 289(6450):951-3. PubMed ID: 6148991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris.
    Dorow P; Schiess W
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):419-22. PubMed ID: 6386704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutical comparison between atenolol and nifedipine in effort angina (author's transl)].
    Gruppillo P; Battaglia R; Masoni C; Maistrello I; Masoni A
    G Ital Cardiol; 1981; 11(12):2081-7. PubMed ID: 7049817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil.
    Gibelli G; Negrini M; Mazzocchi F; Prina L; Pollavini P; De Ponti C
    G Ital Cardiol; 1986 Nov; 16(11):904-8. PubMed ID: 3104124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atenolol once daily in angina.
    Mäkynen P; Karhumäki L; Seppänen S
    Ann Clin Res; 1979 Apr; 11(2):53-7. PubMed ID: 110212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atenolol in the treatment of angina pectoris].
    Bachmann M; Raeber E; Burckhardt D; Schwytzer F; Münch U; Kappenberger L; Nager F
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1857-60. PubMed ID: 531563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation by exercise test of effects of a single oral dose of atenolol in patients with stable angina (author's transl)].
    de Divitiis O; de Simone G; Maddalena G; Castaldo M; Ruggiano A
    G Ital Cardiol; 1981; 11(12):2088-96. PubMed ID: 7049818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monotherapy with nifedipine GITS compared with atenolol in stable angina pectoris. The Working Group on Cardiovascular Research (WCN).
    de Vries RJ; Dunselman PH
    Br J Clin Pract Suppl; 1997 Apr; 88():6-9. PubMed ID: 9519501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the effects and safety of atenolol and nifedipine in the treatment of angina pectoris].
    Aschermann M; Bultas J; Danzig V; Mayer O; Lorenc Z; Vortel J; Kvasnicka J
    Vnitr Lek; 1993 Apr; 39(4):345-52. PubMed ID: 8351862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta-blockader, pindolol, in the therapy of angina pectoris; a report on a multicentric controlled study].
    Lang E; Fitscha P; Schiess W
    Wien Med Wochenschr; 1979 Sep; 129(17):484-8. PubMed ID: 120078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
    Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.